Disc Medicine Sells $720k: CFO Moves After FDA Rejection
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Explore options for retirement accounts at 50. Make informed choices to secure your financial future.
24,046 articlesA biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
As electric-vehicle charging scales up, ChargePoint's 2026 earnings outlook becomes a key signal for investors. This ...
The auto parts sector posted a strong year with a 42% rally, but a prominent investor pulled the trigger on a multi-m...
Two early leaders in the electric air taxi race collide with a policy signal that could tilt the field. This analysis...
When a company CEO sells thousands of shares, investors take notice. This guide breaks down what National Vision's so...
Investors are weighing how legal rulings against Meta could reshape risk and earnings. This guide breaks down what ha...
Investors eye Omada Health as it reports Q1 2026 results. This analysis breaks down the earnings narrative, key metri...
This deep-dive breaks down veru (veru) 2026 earnings, translating the quarterly numbers into a clear sense of cash he...
Ford stock raced 52-week highs this week as the company signals a bold shift toward AI-driven infrastructure. This ar...
Rivian sits at a pivotal crossroads. This in-depth look weighs cash, partnerships, and a road map for growth to answe...
So-Young's Q1 2026 results offer clues about growth momentum and profitability. This article breaks down the numbers,...
A memory themed ETF is drawing intense inflows, triggering questions about momentum versus risk. This guide breaks do...